Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Simon G Thompson Department of
Medical Statistics and Evaluation, Imperial College School of Medicine,
London W12 0NN
Correspondence
to: S G Thompson, MRC Biostatistics Unit, Institute of Public Health,
Cambridge CB2 2SR simon.thompson@mrc-bsu.cam.ac.uk
| The first 150 words of the full text of this article appear below. |
Pragmatic randomised trials are usually large scale multicentre studies in which interventions or medical policies are compared in a realistic setting.1 The intention is that conclusions from these trials, if accepted, can be adopted directly into medical practice.2 Economic evaluations carried out alongside these trials are increasingly common because it is often important to assess costs and cost effectiveness as well as clinical outcomes.3 Costs are usually derived from information about the quantity of healthcare resources used by each patient in the trial. The quantities of each resource used are multiplied by fixed unit cost values and are then summed over the separate types of resource to give a total cost per patient.4
| Table Removed (Available Only in the Full Text) |
This information leads to a range of different costs across
participants in the trial. As an example, the figure shows the distribution of costs in women with menorrhagia randomised to treatment
with endometrial resection or abdominal hysterectomy.5
Read all Rapid Responses